Novel immunoturbidimetric kit for detecting procalcitonin
A procalcitonin, immunoturbidimetric technology, applied in measuring devices, instruments, scientific instruments, etc., can solve the problems of low monoclonal antibody reactivity, false positives, large batch differences, etc., to ensure reliability, eliminate The effect of interference and reducing the difference between batches
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The preparation of mouse anti-human procalcitonin monoclonal combinatorial antibody-conjugated polystyrene latex microspheres includes the following steps:
[0030] The mouse anti-human procalcitonin monoclonal combinatorial antibody was prepared by mixing the monoclonal antibody PCT-124E7, the monoclonal antibody PCT-11B8 and the monoclonal antibody PCT-37G5 in a mass ratio of 1:1:1;
[0031] The average particle size of polystyrene latex microspheres containing carboxyl groups on the surface is 100 nm and the density is 0.03 mmol / g;
[0032] Mix 0.1 mL of polystyrene latex microspheres with carboxyl groups on the surface with 0.9 mL of MES buffer with a pH value of 6.0 and a concentration of 0.01 mol / L, pipette evenly, and add 0.2 mL of EDAC / NHS for activation. The reaction was carried out in a constant temperature shaker at 25°C for 15 min, centrifuged for 30 min under the condition of a centrifugal force of 15,000 g, and the supernatant was removed. The precipitate ...
Embodiment 2
[0034] The preparation of mouse anti-human procalcitonin monoclonal combinatorial antibody-conjugated polystyrene latex microspheres includes the following steps:
[0035] The mouse anti-human procalcitonin monoclonal combinatorial antibody was prepared by mixing the monoclonal antibody PCT-124E7, the monoclonal antibody PCT-11B8 and the monoclonal antibody PCT-37G5 in a mass ratio of 1:1:1;
[0036] The average particle size of the polystyrene latex microspheres containing carboxyl groups on the surface is preferably 400 nm, and the density is 0.30 mmol / g;
[0037] Mix 0.1 mL of polystyrene latex microspheres with carboxyl groups on the surface with 0.9 mL of MES buffer with a pH value of 6.0 and a concentration of 0.01 mol / L, pipette evenly, and add 0.2 mL of EDAC / NHS for activation. The reaction was carried out in a constant temperature shaker at 25°C for 20 min, and the supernatant was removed after centrifugation for 30 min under the condition of a centrifugal force of 15,0...
Embodiment 3
[0039] The preparation of mouse anti-human procalcitonin monoclonal combinatorial antibody-conjugated polystyrene latex microspheres includes the following steps:
[0040] The mouse anti-human procalcitonin monoclonal combinatorial antibody was prepared by mixing the monoclonal antibody PCT-124E7, the monoclonal antibody PCT-11B8 and the monoclonal antibody PCT-37G5 in a mass ratio of 1:1:1;
[0041] The average particle diameter of the polystyrene latex microspheres containing carboxyl groups on the surface is preferably 270 nm, and the density is 0.134 mmol / g;
[0042] Mix 0.1 mL of polystyrene latex microspheres with carboxyl groups on the surface with 0.9 mL of MES buffer with a pH value of 6.0 and a concentration of 0.01 mol / L, pipette evenly, and add 0.2 mL of EDAC / NHS for activation. The reaction was carried out in a constant temperature shaker at 25°C for 20 min, and the supernatant was removed after centrifugation for 30 min under the condition of a centrifugal force ...
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap